ADMA Biologics Inc vs Datadog Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Datadog Inc trades at $243.88 (market cap $88.61B). The key difference: Datadog Inc is far larger — about 39.9× ADMA Biologics Inc's market cap, and Datadog Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | DDOG | |
|---|---|---|
Market Cap | $2.22B | $88.61B |
Sector | Health | Technology |
52-Week High | $20.38 | $288.15 |
52-Week Low | $7.60 | $102.62 |
Enterprise Value | $2.29B | $84.90B |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →